Literature DB >> 10094611

Binary quantitative structure-activity relationship (QSAR) analysis of estrogen receptor ligands.

H Gao1, C Williams, P Labute, J Bajorath.   

Abstract

The use of high throughput screening (HTS) to identify lead compounds has greatly challenged conventional quantitative structure-activity relationship (QSAR) techniques that typically correlate structural variations in similar compounds with continuous changes in biological activity. A new QSAR-like methodology that can correlate less quantitative assay data (i.e., "active" versus "inactive"), as initially generated by HTS, has been introduced. In the present study, we have, for the first time, applied this approach to a drug discovery problem; that is, the study of the estrogen receptor ligands. The binding affinities of 463 estrogen analogues were transformed into a binary data format, and a predictive binary QSAR model was derived using 410 estrogen analogues as a training set. The model was applied to predict the activity of 53 estrogen analogues not included in the training set. An overall accuracy of 94% was obtained.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094611     DOI: 10.1021/ci980140g

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  12 in total

1.  Optimization of a mathematical topological pattern for the prediction of antihistaminic activity.

Authors:  M J Duart; R García-Domenech; G M Antón-Fos; J Gálvez
Journal:  J Comput Aided Mol Des       Date:  2001-06       Impact factor: 3.686

2.  Kinetic analysis of estrogen receptor/ligand interactions.

Authors:  Rebecca L Rich; Lise R Hoth; Kieran F Geoghegan; Thomas A Brown; Peter K LeMotte; Samuel P Simons; Preston Hensley; David G Myszka
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

3.  CoMFA and docking study of novel estrogen receptor subtype selective ligands.

Authors:  Peter Wolohan; David E Reichert
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

Review 4.  Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds.

Authors:  Laszlo Prokai; James W Simpkins
Journal:  Pharmacol Ther       Date:  2007-02-02       Impact factor: 12.310

Review 5.  Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection--what can we learn from earlier mistakes?

Authors:  Johannes Kirchmair; Patrick Markt; Simona Distinto; Gerhard Wolber; Thierry Langer
Journal:  J Comput Aided Mol Des       Date:  2008-01-15       Impact factor: 3.686

6.  Development of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicals.

Authors:  Jennifer C Brennan; Arzoo Bassal; Guochun He; Michael S Denison
Journal:  Environ Toxicol Chem       Date:  2015-12-09       Impact factor: 3.742

7.  Discovery of new β-D-glucosidase inhibitors via pharmacophore modeling and QSAR analysis followed by in silico screening.

Authors:  Reema Abu Khalaf; Ahmed Mutanabbi Abdula; Mohammad S Mubarak; Mutasem O Taha
Journal:  J Mol Model       Date:  2010-05-21       Impact factor: 1.810

Review 8.  Machine learning in chemoinformatics and drug discovery.

Authors:  Yu-Chen Lo; Stefano E Rensi; Wen Torng; Russ B Altman
Journal:  Drug Discov Today       Date:  2018-05-08       Impact factor: 7.851

Review 9.  In silico prediction of drug toxicity.

Authors:  John C Dearden
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

10.  QSAR models for predicting cathepsin B inhibition by small molecules--continuous and binary QSAR models to classify cathepsin B inhibition activities of small molecules.

Authors:  Zhigang Zhou; Yanli Wang; Stephen H Bryant
Journal:  J Mol Graph Model       Date:  2010-02-01       Impact factor: 2.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.